The IMI Partnering Platform (set up by the German National Contact Point Life Sciences with support from the German Federal Ministry of Education and Research) has been re-launched for IMI2 and updated with regard to the 1st IMI2 call topics. All information regarding IMI 2 future Calls for proposals is indicative and subject the agreement of the IMI2 Governing Board on the Call topics.
The Platform is especially dedicated to IMI2 which provides excellent networking opportunities to prepare for the 1st IMI2 Call 2014 with the following topics:
1) Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
2) Discovery and validation of novel endpoints in dry age-related macular degeneration and diabetic retinopathy
The IMI2 Partnering Platform allows potential IMI2 applicants to identify suitable cooperation partners for the 1st Call of the Innovative Medicines Initiative2. The IMI2 Partnering Platform does not only facilitate the quick and targeted search for possible partners but also displays European-wide cooperation offers specific to IMI2.
Networking via the Platform is open to all IMI2 applicants on the European level. Up to know more than 950 profiles including 226 SMEs from 38 different countries are published!
For more info about IMI and IMI2, we kindly invite you to join us on 11th June for our webinar: